Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
An. acad. bras. ciênc ; 90(1): 185-194, Mar. 2018. tab, graf
Article in English | LILACS | ID: biblio-886919

ABSTRACT

ABSTRACT The N-salicyloyltryptamine (NST) is an indole derivative compound analogue to the alkaloid N-benzoyltryptamine. In the present study, the antiedematogenic activity of NST was investigated in animal models. Firstly, the acute toxicity for NST was assessed according to the OECD Guideline no. 423. The potential NST-induced antiedematogenic activity was evaluated by carrageenan-induced paw edema in rats, as well as by dextran-, compound 48/80-, histamine-, serotonin-, capsaicine-, and prostaglandin E2-induced paw edema in mice. The effect of NST on compound 48/80-induced ex vivo mast cell degranulation on mice mesenteric bed was investigated. No death or alteration of behavioral parameters was observed after administration of NST (2000 mg/kg, i.p.) during the observation time of 14 days. The NST (100 and 200 mg/kg, i.p.) inhibited the carrageenan-induced edema from the 1st to the 5th hour (**p<0.01; ***p<0.001). The edematogenic activity induced by dextran, compound 48/80, histamine, serotonin, capsaicin, and prostaglandin E2 was inhibited by NST (100 mg/kg, i.p.) throughout the observation period (**p<0.01; ***p<0.001). The pretreatment with NST (50, 100 or 200 mg/kg, i.p) attenuates the compound 48/80-induced mast cell degranulation (**p<0.01; ***p<0.001). Thus, the inhibition of both mast cell degranulation and release of endogenous mediators are probably involved in the NST-induced antiedematogenic effect.


Subject(s)
Animals , Male , Female , Rats , Tryptamines/pharmacology , Salicylates/pharmacology , Edema/drug therapy , Anti-Inflammatory Agents/pharmacology , Peptides/drug effects , Time Factors , Carrageenan , Tryptamines/toxicity , Salicylates/toxicity , Rats, Wistar , Inflammation Mediators , Disease Models, Animal , Edema/chemically induced , Hindlimb , Anti-Inflammatory Agents/toxicity
2.
Braz. j. microbiol ; 46(1): 49-57, 05/2015. tab, graf
Article in English | LILACS | ID: lil-748247

ABSTRACT

Bauhinia forficata is native to South America and used with relative success in the folk medicine in Brazil. The diversity, antibacterial activity, and extracellular hydrolytic enzymes of endophytic fungi associated with this plant were studied. Plant samples, which included leaves, sepals, stems, and seeds, were used. Ninety-five endophytic fungal were isolated (18 from leaves, 22 from sepals, 46 from stems, and nine from seeds), comprising 28 species. The most frequently isolated species were Acremonium curvulum (9.5%), Aspergillus ochraceus (7.37%), Gibberella fujikuroi (10.53%), Myrothecium verrucaria (10.53%) and Trichoderma piluliferum (7.37%). Diversity and species richness were higher in stem tissues, and Sorensen’s index of similarity between the tissues was low. Eleven fungi showed antibacterial activity. Aspergillus ochraceus, Gibberella baccata, Penicillium commune, and P. glabrum were those with the greatest antibacterial activity against Staphylococcus aureus and/or Streptococcus pyogenes. Thirteen species showed proteolytic activity, particularly Phoma putaminum. Fourteen species were cellulase positive, particularly the Penicillium species and Myrmecridium schulzeri. All isolates tested were xylanase positive and 10 showed lipolytic activity, especially Penicillium glabrum. It is clear that the endophytic fungi from B. forficata have potential for the production of bioactive compounds and may be a source of new therapeutic agents for the effective treatment of diseases in humans, other animals, and plants. To our knowledge, this is the first study of endophytic fungi from different tissues of B. forficata and their biotechnological potential.


Subject(s)
Anti-Infective Agents/metabolism , Biodiversity , Bauhinia/microbiology , Endophytes/classification , Fungi/metabolism , Hydrolases/metabolism , Plants, Medicinal/microbiology , Brazil , Bacteria/drug effects , Biological Products/metabolism , Biotechnology/methods , Endophytes/isolation & purification , Endophytes/metabolism , Fungi/classification , Fungi/isolation & purification , Microbial Sensitivity Tests , South America , Technology, Pharmaceutical/methods
SELECTION OF CITATIONS
SEARCH DETAIL